Understanding HER2: What Patients Need to Know
This first session, Understanding HER2: What Patients Need to Know, brings together leading experts and advocates to discuss HER2-positive metastatic colorectal cancer (mCRC) and emerging clinical trial opportunities — including insights from the MOUNTAINEER study.










